TD Cowen upgraded Milestone Pharmaceuticals (MIST) to Buy from Hold with an $8 price target
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MIST:
- Milestone Pharmaceuticals Poised for Success with Cardamyst Approval and Strong Market Potential
- Milestone Pharmaceuticals price target raised to $8 from $5 at H.C. Wainwright
- Milestone Pharmaceuticals Gains FDA Approval for CARDAMYST
- Milestone Pharmaceuticals receives FDA approval of CARDAMYST
- Milestone Pharmaceuticals trading halted, news pending